| Name | Jollys Pharmacy |
|---|---|
| Organization Name | Jollys Pharmacy Inc |
| Location | 1412 Sw 43rd St #120b, Renton, Washington 98057 |
| Type | Long Term Care Pharmacy |
| Phone | (425) 251-6335 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
The new mandate to buy health insurance has now reached the Supreme Court, which agreed on Monday to judge its constitutionality. The crux of the constitutional complaint against the mandate is that Congress's ability to regulate commerce has never been understood to give it the power to force Americans to buy insurance, or anything else. But not only is there a precedent for this, there is also clear support for it in the Constitution.
› Verified 4 days ago
| NPI Number | 1235388430 |
| Organization Name | JOLLYS PHARMACY INC |
| Doing Business As | READY MEDS PHARMACY |
| Type | Long Term Care Pharmacy |
| Address | 1412 Sw 43rd St, Suite 120, Renton, WA 98057 |
| Phone Number | 425-251-6335 |
News Archive
The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
The new mandate to buy health insurance has now reached the Supreme Court, which agreed on Monday to judge its constitutionality. The crux of the constitutional complaint against the mandate is that Congress's ability to regulate commerce has never been understood to give it the power to force Americans to buy insurance, or anything else. But not only is there a precedent for this, there is also clear support for it in the Constitution.
› Verified 4 days ago
| NPI Number | 1306338868 |
| Organization Name | MANHATTAN VILLAGE PHARMACY INC. |
| Doing Business As | READY MEDS PHARMACY |
| Type | Long Term Care Pharmacy |
| Address | 10102 E Knox Ave Ste 400, Spokane Valley, WA 99206 |
| Phone Number | 425-251-6335 |
News Archive
The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
The new mandate to buy health insurance has now reached the Supreme Court, which agreed on Monday to judge its constitutionality. The crux of the constitutional complaint against the mandate is that Congress's ability to regulate commerce has never been understood to give it the power to force Americans to buy insurance, or anything else. But not only is there a precedent for this, there is also clear support for it in the Constitution.
› Verified 4 days ago
| NPI Number | 1386195048 |
| Organization Name | REDDI ENTERPRISES INC |
| Type | Community/Retail Pharmacy |
| Address | 1412 Sw 43rd St, 120, Renton, WA 98057 |
| Phone Number | 425-251-6335 |
News Archive
The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
The new mandate to buy health insurance has now reached the Supreme Court, which agreed on Monday to judge its constitutionality. The crux of the constitutional complaint against the mandate is that Congress's ability to regulate commerce has never been understood to give it the power to force Americans to buy insurance, or anything else. But not only is there a precedent for this, there is also clear support for it in the Constitution.
› Verified 4 days ago
| NPI Number | 1750948956 |
| Organization Name | LACEY SQUARE PHARMACY INC |
| Type | Long Term Care Pharmacy |
| Address | 6020 Pacific Ave Se Ste C, Lacey, WA 98503 |
| Phone Number | 425-251-6335 |
News Archive
The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
The new mandate to buy health insurance has now reached the Supreme Court, which agreed on Monday to judge its constitutionality. The crux of the constitutional complaint against the mandate is that Congress's ability to regulate commerce has never been understood to give it the power to force Americans to buy insurance, or anything else. But not only is there a precedent for this, there is also clear support for it in the Constitution.
› Verified 4 days ago
| NPI Number | 1801817861 |
| Organization Name | REDDI ENTERPRISES INC |
| Doing Business As | READY MEDS PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1412 Sw 43rd St Ste 120, Renton, WA 98057 |
| Phone Number | 425-251-6335 |
News Archive
The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
The new mandate to buy health insurance has now reached the Supreme Court, which agreed on Monday to judge its constitutionality. The crux of the constitutional complaint against the mandate is that Congress's ability to regulate commerce has never been understood to give it the power to force Americans to buy insurance, or anything else. But not only is there a precedent for this, there is also clear support for it in the Constitution.
› Verified 4 days ago
News Archive
The U.S. Department of Health and Human Services' Office of the Assistant Secretary of Preparedness and Response awarded $3 million to University Hospitals Rainbow Babies & Children's Hospital to establish a Pediatric Disaster Care Center of Excellence.
Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.
Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes.
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
The new mandate to buy health insurance has now reached the Supreme Court, which agreed on Monday to judge its constitutionality. The crux of the constitutional complaint against the mandate is that Congress's ability to regulate commerce has never been understood to give it the power to force Americans to buy insurance, or anything else. But not only is there a precedent for this, there is also clear support for it in the Constitution.
› Verified 4 days ago
Rotech Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1000 Sw 7th Street, Renton, Washington 98057 Phone: (253) 926-0474 | |
Fred Meyer Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17801 108th Avenue Se, Renton, Washington 98055 Phone: (425) 235-5383 | |
Fred Meyer Pharmacy #459 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 365 Renton Center Swway, Renton, Washington 98057 Phone: (425) 204-5233 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 401 Sw 41st St, Renton, Washington 98057 Phone: (425) 251-3227 | |
Jollys Pharmacy Type: Long Term Care Pharmacy Location: 1412 Sw 43rd St #120b, Renton, Washington 98057 Phone: (425) 251-6335 |